- Home
- NUS vs BDN Comparison
NUS vs BDN Comparison
Compare NUS & BDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUS
- BDN
- Stock Information
- Founded
- NUS 1984
- BDN 1986
- Country
- NUS United States
- BDN United States
- Employees
- NUS N/A
- BDN N/A
- Industry
- NUS Other Pharmaceuticals
- BDN Real Estate Investment Trusts
- Sector
- NUS Health Care
- BDN Real Estate
- Exchange
- NUS Nasdaq
- BDN Nasdaq
- Market Cap
- NUS 596.0M
- BDN 693.1M
- IPO Year
- NUS 1996
- BDN N/A
- Fundamental
- Price
- NUS $11.85
- BDN $4.47
- Analyst Decision
- NUS Hold
- BDN Hold
- Analyst Count
- NUS 2
- BDN 2
- Target Price
- NUS $6.88
- BDN $4.50
- AVG Volume (30 Days)
- NUS 482.2K
- BDN 2.0M
- Earning Date
- NUS 11-06-2025
- BDN 10-21-2025
- Dividend Yield
- NUS 2.02%
- BDN 13.44%
- EPS Growth
- NUS N/A
- BDN N/A
- EPS
- NUS 2.03
- BDN N/A
- Revenue
- NUS $1,626,325,000.00
- BDN $306,596,000.00
- Revenue This Year
- NUS N/A
- BDN $55.21
- Revenue Next Year
- NUS $0.98
- BDN $3.34
- P/E Ratio
- NUS $5.86
- BDN N/A
- Revenue Growth
- NUS N/A
- BDN N/A
- 52 Week Low
- NUS $5.32
- BDN $3.41
- 52 Week High
- NUS $12.41
- BDN $6.54
- Technical
- Relative Strength Index (RSI)
- NUS 58.15
- BDN 60.89
- Support Level
- NUS $11.60
- BDN $4.40
- Resistance Level
- NUS $12.10
- BDN $4.60
- Average True Range (ATR)
- NUS 0.43
- BDN 0.12
- MACD
- NUS -0.13
- BDN 0.02
- Stochastic Oscillator
- NUS 50.94
- BDN 68.89
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
About BDN Brandywine Realty Trust
Brandywine Realty Trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of a portfolio of office, life science/lab, residential, and mixed-use properties. The company owned and managed properties within five segments. The Philadelphia CBD segment includes properties located in the City of Philadelphia in Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware and Montgomery counties in the Philadelphia suburbs. The Austin, Texas segment includes properties in the City of Austin, Texas. The Metropolitan Washington, D.C. segment includes properties in Northern Virginia, Washington, D.C. and Southern Maryland. The Other segment includes properties in Camden County, New Jersey and New Castle County, Delaware.